Literature DB >> 11573101

Colonic disorders in adult cystic fibrosis.

H Chaun1.   

Abstract

By 1996, the median survival of patients with cystic fibrosis (CF) in North America had increased to 31 years. With the markedly improved life expectancy, many CF patients are now adults. There is an associated increased risk of certain colonic disorders, and the emergence of other previously unrecognized disorders, in adult CF patients. The distal intestinal obstruction syndrome (DIOS), which is more common in older patients, is a frequent cause of abdominal pain. Intussusception may complicate DIOS; other differential diagnoses include appendiceal disease, volvolus, Crohn's disease, fibrosing colonopathy and colonic carcinoma. The diagnosis of acute appendicitis, although uncommon in patients with CF, is often delayed, and appendiceal abscess is a frequent complication. The prevalence of Crohn's disease in CF has been shown to be 17 times that of the general population. Right-sided microscopic colitis is a recently recognized entity in CF of uncertain clinical significance. Fibrosing colonopathy has been confined mostly to children with CF, attributed to the use of high strength pancreatic enzyme supplements, but it has been reported in three adults. Nine cases of carcinoma of the large intestine have been reported worldwide, associated with an apparent excess risk of digestive tract cancers in CF. Despite high carrier rates of Clostridium difficile in patients with CF, pseudomembranous colitis is distinctly rare, but severe cases complicated by toxic megacolon have been reported. In these patients, watery diarrhea is often absent. Adult CF patients with refractory or unexplained intestinal symptoms merit thorough investigations.

Entities:  

Mesh:

Year:  2001        PMID: 11573101     DOI: 10.1155/2001/745361

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  9 in total

1.  Distal intestinal obstruction syndrome in the early postoperative period after lung transplantation in a patient with cystic fibrosis: morphological findings on computed tomography.

Authors:  K Nassenstein; B Schweiger; M Kamler; J Stattaus; T Lauenstein; J Barkhausen
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

2.  Appendicitis in an adult patient with cystic fibrosis: a diagnostic challenge.

Authors:  Yahya Al-Abed; Yahya Al Abed; W Hameed; J Roy; A P S Kumar
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

Review 3.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

4.  Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation.

Authors:  B Yates; D M Murphy; A J Fisher; F K Gould; J L Lordan; J H Dark; P A Corris
Journal:  BMJ Case Rep       Date:  2009-05-08

5.  Intussusception in an adult with cystic fibrosis successfully reduced with contrast enema.

Authors:  Morten Thorsteinsson; Stefan Kobbelgaard Burgdorf; Luit Penninga
Journal:  BMJ Case Rep       Date:  2015-07-07

6.  Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation.

Authors:  B Yates; D M Murphy; A J Fisher; F K Gould; J L Lordan; J H Dark; P A Corris
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

7.  Radiographic reduction of intussusception in patients with cystic fibrosis.

Authors:  Benjamin Pomerantz; Sudha Anupindi; Paul W Wales; Daniel P Doody; Peter T Masiakos
Journal:  Pediatr Surg Int       Date:  2007-06-27       Impact factor: 1.827

8.  Treatment of Gastrointestinal Problems in Cystic Fibrosis.

Authors:  Maria R. Mascarenhas
Journal:  Curr Treat Options Gastroenterol       Date:  2003-10

9.  Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients.

Authors:  John F Pohl; Raza Patel; Jeffery T Zobell; Ellen Lin; E Kent Korgenski; Kody Crowell; Mark W Mackay; Aleesha Richman; Christian Larsen; Barbara A Chatfield
Journal:  Gastroenterol Res Pract       Date:  2011-11-15       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.